OTS.at - aktuelle Inhalte in Text, Bild, Ton und Video

Eli Lilly and Company

New Online Tool Helps Patient Advocates Navigate Medicines Development and Evaluation Process

Indianapolis (ots/PRNewswire) - A new online, interactive training programme designed to help patient advocates better influence decisions related to access to new medicines was launched today in advance of the...

24.03.2014, 10:12:13
/
OTE0002

Eli Lilly and Company

Lilly CEO Says Industry, Public Policy Must Pave Way For Innovation

London (ots/PRNewswire) - A new approach to research, along with public policies that support medical innovation, will help biopharmaceutical companies address stubborn diseases with potentially devastating personal...

10.02.2011, 10:17:33
/
OTE0005

Eli Lilly and Company

Mortality Data Presented for Patients Treated with Efient(R)/Effient(R) (Prasugrel) Who Underwent Isolated Coronary Artery Bypass Surgery

Chicago, November 16 (ots/PRNewswire) - New results from an observational substudy from TRITON-TIMI 38 presented today at the American Heart Association (AHA) Scientific Sessions annual meeting showed that patients...

16.11.2010, 16:03:03
/
OTE0007

Eli Lilly and Company

Lilly Halts Development of Semagacestat for Alzheimer's Disease Based on Preliminary Results of Phase III Clinical Trials

Indianapolis, August 17, 2010 (ots/PRNewswire) - Eli Lilly and Company will halt development of semagacestat, a gamma secretase inhibitor being studied as a potential treatment for Alzheimer's disease, because preliminary...